Bispecific Antibody Separation via pH Gradient Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for separating bispecific antibodies from monospecific antibodies and mismatched bispecific antibodies are inefficient, leading to the production of non-functional or unwanted molecules due to promiscuous pairing of light and heavy chains, which complicates the purification process.
Innovation Solution
A method utilizing a pH gradient when eluting bispecific antibodies from a Protein A ligand chromatography matrix, specifically using a pH range from about 6 to 2, to separate bispecific antibodies or antibody fragments based on the presence of a VH3-chain, allowing for the use of commercially available Protein A ligands with maintained VH3 interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If Protein A ligand chromatography is used for antibody purification, then high affinity and selectivity are achieved, but separation of bisspecific antibodies from monospecific antibodies is insufficient
Solution Approach 1:
The patent applies parameter changes by utilizing a pH gradient during elution to separate antibodies based on their different binding affinities to Protein A at varying pH levels. Bispecific antibodies with VH3 chains exhibit different elution behaviors compared to monospecific antibodies, enabling separation through pH-controlled elution rather than relying solely on affinity differences at constant pH.
Solution Approach 2:
The patent replaces traditional mechanical or physical separation methods with a biochemical approach using pH-gradient elution. Instead of relying on size exclusion or other physical properties, the method substitutes a chemical parameter (pH) to modulate the interaction between antibodies and Protein A, achieving separation based on subtle affinity differences.
2Adaptability or versatility
If promiscuous pairing of light and heavy chains is allowed, then diverse antibody combinations are produced, but non-functional or unwanted molecules are generated
Solution Approach 1:
The patent extracts or isolates the desired bispecific antibodies from the complex mixture containing various pairing combinations. By using pH-gradient elution, the method selectively extracts functional bispecific antibodies with the correct chain pairings, separating them from non-functional or unwanted molecules generated by promiscuous pairing.
Solution Approach 2:
The patent introduces pH gradient as an intermediary parameter to mediate the separation process. This intermediary allows for the discrimination between correctly paired and incorrectly paired antibodies by exploiting differences in their Protein A binding characteristics under varying pH conditions, without directly interfering with the antibody structure.
3Ease of manufacture
If traditional affinity chromatography is used, then simple purification is achieved, but separation of mismatched bispecific antibodies is not possible
Solution Approach 1:
The patent introduces dynamics into the traditionally static affinity chromatography process by implementing a pH gradient during elution. Instead of using a constant pH buffer, the method dynamically changes pH conditions to modulate antibody-Protein A interactions, enabling separation based on subtle affinity differences while maintaining the simplicity of affinity chromatography.
Solution Approach 2:
The patent changes the pH parameter during the elution phase to achieve separation. By gradually changing pH conditions, the method enables discrimination between different antibody types that would otherwise co-elute under constant pH conditions, enhancing separation capability without fundamentally changing the affinity chromatography approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively separates bispecific antibodies from monospecific antibodies and mismatched bispecific antibodies, ensuring that antibodies with one VH3-chain elute prior to those with two VH3-chains, thereby improving the purification efficiency and productivity of bispecific antibody production.
Implementation Method 1
Affinity chromatography is used in most cases, as one of the key steps in the purification of immunoglobulin molecules... An example of such a protein is staphylococcal protein A, containing domains capable of binding to the Fc and Fab portions of IgG immunoglobulins
Implementation Method 2
The separation is performed by using a pH gradient when eluting bispecific antibodies from a Protein A ligand chromatography matrix
Data Source
AI summary
The present invention relates to a method of separating bispecific antibodies or bispecific antibody fragments. The method comprises the steps of a) providing a feed comprising bispecific antibodies or bispecific antibody fragments; b) contacting the feed with a separation matrix having affinity ligands coupled to a support; c) optionally washing the separation resin with a washing liquid; d) applying an elution buffer to the separation resin, to elute the antibodies or antibody fragments bound to the affinity ligand; wherein in step d) a pH gradient is applied over the elution buffer, said pH gradient being from about 6 to about 2.